Evidence map›Paper›PMID 17393451›Full record

ArticleArthritis and rheumatism2007

Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model.

Jun-Qi Yang, Xiangshu Wen, Hongzhu Liu, Gbolahan Folayan, Xin Dong, Min Zhou, Luc Van Kaer, Ram Raj Singh

Open access · greenAbstract read
In one paragraph

Article in Arthritis and rheumatism, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Unconventional T cells and kidney disease.Nature reviews. Nephrology · 2021
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. O death where is thy sting? Immunologic tolerance to apoptotic self.Cellular and molecular life sciences : CMLS · 2013
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jun-Qi YangUniversity of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Xiangshu Wen
Hongzhu Liu
Gbolahan Folayan
Xin Dong
Min Zhou
Luc Van Kaer
Ram Raj Singh
University of Cincinnati Medical Center · USUniversity of California, Los Angeles · USVanderbilt University · US

Funding

T Lymphocyte based functional genomics of inflammationP01HL068744 · NHLBI · VANDERBILT UNIVERSITY · PI MOORE, JASON H. · 2002 to 2006
$9.9M
MOLECULAR BASIS OF CDLDL AND NATURAL T CELL FUNCTIONR01AI042284 · NIAID · VANDERBILT UNIVERSITY · PI JOYCE, SEBASTIAN · 1998 to 2013
$3.1M
Kidney Damage in Murine LupusR01AR050797 · NIAMS · UNIVERSITY OF CINCINNATI · PI SINGH, RAM RAJ · 2003 to 2006
$1.4M
Peptide Gene Vaccination in LupusR01AR047322 · NIAMS · UNIVERSITY OF CINCINNATI · PI SINGH, RAM RAJ · 2001 to 2005
$1.3M
Molecular Basis of CD1d1 and Natural T Cell FunctionR21AI042284 · NIAID · VANDERBILT UNIVERSITY · PI JOYCE, SEBASTIAN · 2002 to 2002
$302k
NHLBI NIH HHS HL-68744NHLBI NIH HHS P01 HL068744NIAID NIH HHS AI-042284NIAID NIH HHS R01 AI042284NIAID NIH HHS R21 AI042284NIAMS NIH HHS AR-47322NIAMS NIH HHS AR-50797NIAMS NIH HHS R01 AR047322NIAMS NIH HHS R01 AR050797
6 · The paper itself

Abstract

objectiveCD1d-reactive invariant natural killer T (iNKT) cells secrete multiple cytokines upon T cell receptor (TCR) engagement and modulate many immune-mediated conditions. The purpose of this study was to examine the role of these cells in the development of autoimmune disease in genetically lupus-prone (NZBxNZW)F1 (BWF1) mice.

methodsThe CD1d1-null genotype was crossed onto the NZB and NZW backgrounds to establish CD1d1-knockout (CD1d0) BWF1 mice. CD1d0 mice and their wild-type littermates were monitored for the development of nephritis and assessed for cytokine responses to CD1d-restricted glycolipid alpha-galactosylceramide (alphaGalCer), anti-CD3 antibody, and concanavalin A (Con A). Thymus and spleen cells were stained with CD1d tetramers that had been loaded with alphaGalCer or its analog PBS-57 to detect iNKT cells, and the cells were compared between BWF1 mice and class II major histocompatibility complex-matched nonautoimmune strains, including BALB/c, (BALB/cxNZW)F1 (CWF1), and NZW.

resultsCD1d0 BWF1 mice had more severe nephritis than did their wild-type littermates. Although iNKT cells and iNKT cell responses were absent in CD1d0 BWF1 mice, the CD1d0 mice continued to have significant numbers of interferon-gamma-producing NKT-like (CD1d-independent TCRbeta+,NK1.1+ and/or DX5+) cells. CD1d deficiency also influenced cytokine responses by conventional T cells: upon in vitro stimulation of splenocytes with Con A or anti-CD3, type 2 cytokine levels were reduced, whereas type 1 cytokine levels were increased or unchanged in CD1d0 mice as compared with their wild-type littermates. Additionally, numbers of thymic iNKT cells were lower in young wild-type BWF1 mice than in nonautoimmune strains.

conclusionGermline deletion of CD1d exacerbates lupus in BWF1 mice. This finding, together with reduced thymic iNKT cells in young BWF1 mice as compared with nonautoimmune strains, implies a regulatory role of CD1d and iNKT cells during the development of lupus.

Indexed as

Genetic Predisposition to DiseaseAnimalsAntigens, CD1Antigens, CD1dCells, CulturedDisease Models, AnimalGalactosylceramidesGene SilencingInterferon-gammaKiller Cells, NaturalLupus Erythematosus, SystemicLupus NephritisMiceMice, Inbred BALB CMice, Inbred NZBMice, KnockoutAntigens, CD1Antigens, CD1dGalactosylceramidesInterferon-gammaPBS 57

Identifiers

PMID17393451
PMCPMC2291538
OpenAlexW2005167887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.